Hepatitis B Immunoglobulin (HBIg)

DRUG3 trials

Sponsors

GlaxoSmithKline, Gilead Sciences, Peking University People's Hospital

Conditions

Chronic Hepaititis BChronic Hepatitis BHepatitis B

Early Phase 1

Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B

RecruitingNCT07328711

Peking University People's HospitalChronic Hepaititis B

Start: 2026-01-01End: 2028-12-31Target: 132Updated: 2026-01-09

Phase 2

Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant

CompletedNCT00507689

Gilead SciencesChronic Hepatitis B

Start: 2007-09-30End: 2011-05-31Updated: 2014-03-14

Phase 4

LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers

CompletedNCT00240526

GlaxoSmithKlineHepatitis B

Start: 2003-10-31End: 2010-03-31Updated: 2016-12-07

Related Papers

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers.

2012-07-0140 citations